CN Stock MarketDetailed Quotes

300039 Shanghai Kaibao Pharmaceutical

Watchlist

6.06
-0.01-0.16%

Trading Apr 25 13:59 CST

6.34BMarket Cap17.07P/E (TTM)

Shanghai Kaibao Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q3)Mar 31, 2025

(FY)Dec 31, 2024

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

Assets

Current assets

Money funds

-14.19%686.18M

-1.43%593.31M

110.53%1.2B

14.21%665.56M

11.83%799.69M

-13.35%601.94M

-60.42%571.46M

-56.46%582.75M

-46.91%715.12M

-48.35%694.69M

Transactional financial assets

62.40%192.92M

20.00%180.02M

-24.97%120.44M

253.30%116.18M

27.20%118.8M

10.24%150.01M

1.18%160.52M

-69.71%32.89M

-19.46%93.39M

165.45%136.07M

Notes receivable and accounts receivable

-8.09%520.41M

-10.83%471.99M

-13.66%439.89M

-16.98%526.06M

-12.39%566.23M

-0.19%529.32M

-3.48%509.51M

22.89%633.63M

3.00%646.29M

-6.63%530.33M

-Notes receivable

-8.50%199.24M

-2.18%155.49M

-31.18%153.31M

-27.76%208.57M

-14.50%217.75M

2.13%158.96M

4.85%222.77M

41.15%288.71M

4.03%254.7M

-29.76%155.65M

-Accounts receivable

-7.84%321.17M

-14.54%316.5M

-0.05%286.58M

-7.96%317.48M

-11.01%348.48M

-1.15%370.36M

-9.10%286.73M

10.88%344.93M

2.34%391.59M

8.17%374.68M

Other receivables (including interest and dividends)

-98.16%230.63K

-69.95%124.54K

-99.08%526.39K

-98.82%346K

-49.52%12.54M

-98.84%414.42K

-1.79%56.99M

-55.02%29.31M

-56.64%24.85M

-23.53%35.77M

-Accrued interest receivable

----

-29.26%36.73M

-54.53%26.72M

-58.86%21.49M

-23.82%34.84M

-Other receivable

----

-86.65%346K

----

-55.28%414.42K

----

-59.54%2.59M

----

-10.78%926.6K

Advance payment

323.68%25.11M

-3.75%6.55M

-38.24%16.45M

106.06%68.97M

-63.79%5.93M

-47.34%6.81M

250.10%26.64M

36.61%33.47M

263.66%16.37M

29.84%12.93M

Inventories

16.85%186.01M

9.35%187.85M

13.51%188.41M

-0.43%151.72M

1.63%159.19M

6.84%171.79M

2.93%165.98M

-3.19%152.37M

-4.86%156.64M

-2.63%160.8M

Non-current assets due within one year

--1.09B

--924.87M

----

Other current assets

-43.25%10.15M

247.08%50.64M

215.32%45.71M

299.24%26.03M

223.00%17.88M

279.90%14.59M

15,194.64%14.5M

-49.01%6.52M

-53.33%5.54M

-61.71%3.84M

Total current assets

61.35%2.71B

63.77%2.42B

33.80%2.01B

5.71%1.55B

1.33%1.68B

-6.32%1.47B

-36.13%1.51B

-35.51%1.47B

-30.53%1.66B

-30.16%1.57B

Non Current assets

Other equity investment

22.03%1.05B

-18.90%1.02B

-21.37%920.64M

-54.39%603.69M

-45.54%860.09M

0.36%1.26B

-13.77%1.17B

-41.01%1.32B

98.27%1.58B

87.92%1.26B

Other non-current financial assets

7.62%51.53M

3.93%47.89M

9.77%46.07M

Long-term equity investment

----

-58.26%7.25M

-51.56%8.41M

--8.41M

Fixed assets

----

-3.28%276.44M

----

-2.99%289.57M

----

10.79%285.81M

----

9.08%298.49M

Constru in process

----

-94.40%884.02K

----

-91.58%520K

----

-65.44%15.77M

----

-81.91%6.18M

Intangible assets

277.31%167.5M

274.20%168.8M

285.85%170.15M

281.57%171.45M

2.15%44.39M

1.99%45.11M

7.15%44.1M

7.65%44.93M

2.69%43.46M

3.09%44.23M

Goodwill

----

-34.46%9.04M

Long deferred expense

994.94%2.32M

1,051.84%2.44M

384.78%1.83M

419.53%1.67M

-28.12%212.16K

-34.29%212.16K

--376.99K

--321.64K

--295.18K

--322.86K

Deferred tax assets

-25.34%24.39M

-6.87%29.44M

74.46%27.87M

39.14%25.19M

77.74%32.67M

73.08%31.61M

-5.14%15.98M

17.12%18.1M

18.71%18.38M

20.93%18.26M

Other non current assets

-69.44%408.91M

-60.81%559.67M

-33.16%874.64M

-1.48%1.29B

22.43%1.34B

43.31%1.43B

--1.31B

12,829.63%1.09B

9,165.66%996.49M

Total non current assets

-24.44%1.97B

-32.26%2.1B

-20.15%2.31B

-21.02%2.42B

-15.90%2.61B

15.64%3.1B

60.98%2.9B

14.24%3.06B

150.91%3.1B

143.77%2.68B

Total assets

9.18%4.68B

-1.34%4.52B

-1.70%4.33B

-12.34%3.97B

-9.89%4.29B

7.52%4.58B

5.91%4.4B

-8.64%4.53B

31.34%4.76B

26.92%4.26B

Liabilities

Current liabilities

Short term loan

--6.17M

--5.42M

--2.99M

----

Notes payable and accounts payable

2.53%202.22M

-26.31%99.37M

91.47%218.99M

26.36%229.97M

23.45%197.23M

48.17%134.85M

39.64%114.38M

198.12%182M

34.29%159.77M

21.32%91.01M

-Accounts payable

2.53%202.22M

-26.31%99.37M

91.47%218.99M

26.36%229.97M

23.45%197.23M

48.17%134.85M

39.64%114.38M

198.12%182M

34.29%159.77M

21.32%91.01M

Contract liabilities

-48.70%14.46M

-60.34%18.12M

2.20%18.97M

-39.91%15.58M

13.03%28.18M

14.10%45.69M

18.74%18.56M

7,829.67%25.93M

1,070.30%24.93M

1,289.74%40.04M

Advance receipts

--165K

----

Salaries payable

-47.10%550.73K

-44.92%1.08M

72.36%7.11M

68.12%7.37M

8.37%1.04M

148.97%1.96M

72.07%4.12M

123.54%4.38M

-22.66%960.67K

-59.15%788.02K

Taxs payable

-38.05%25.1M

-6.60%57.29M

-44.96%18.98M

-6.97%19.87M

32.35%40.52M

-3.54%61.34M

11.45%34.48M

7.45%21.35M

-2.36%30.61M

288.70%63.59M

Other payable (including interest and dividends)

-73.63%23.03M

-42.11%47.83M

-77.56%45.43M

-59.86%71.3M

-48.65%87.33M

-6.42%82.62M

95.12%202.49M

65.12%177.64M

52.59%170.06M

2.16%88.29M

-Other payable

----

-59.86%71.3M

----

-6.42%82.62M

----

65.12%177.64M

----

2.16%88.29M

Other current liabilities

321.63%13.06M

-63.97%3.02M

-63.95%4.19M

-65.76%5.96M

-57.60%3.1M

-31.45%8.39M

85.97%11.64M

--17.4M

-18.25%7.31M

51.63%12.24M

Total current liabilities

-20.33%284.74M

-30.62%232.3M

-17.89%316.66M

-18.35%350.05M

-9.21%357.39M

13.14%334.85M

60.09%385.66M

124.70%428.7M

43.62%393.63M

55.21%295.96M

Current liabilities

Deferred tax liabilities

28.21%139.04M

-19.91%135.11M

-21.49%117.53M

-59.46%69.99M

-48.62%108.45M

3.65%168.71M

-15.11%149.7M

-44.17%172.65M

128.98%211.07M

122.79%162.77M

Long term deferred income

14.57%47.5M

11.03%48.03M

-14.58%38.7M

6.36%40.11M

8.87%41.46M

9.49%43.26M

3.66%45.31M

-16.48%37.71M

-16.64%38.08M

-16.23%39.51M

Total non current liabilities

24.44%186.54M

-13.60%183.15M

-19.89%156.23M

-47.66%110.1M

-39.83%149.9M

4.79%211.97M

-11.38%195.01M

-40.64%210.37M

80.73%249.15M

68.25%202.28M

Total liabilities

-7.10%471.28M

-24.02%415.45M

-18.56%472.89M

-28.00%460.15M

-21.08%507.29M

9.75%546.82M

25.97%580.67M

17.22%639.07M

56.04%642.78M

60.25%498.24M

Shareholders equity

Paid-in capital

0.00%1.05B

Capital reserve funds

0.00%8.62M

Surplus reserve funds

14.36%288.62M

16.09%252.36M

16.09%252.37M

13.35%217.39M

Retained profit

12.31%2.12B

13.15%2.03B

12.30%1.91B

11.90%1.84B

14.47%1.89B

14.68%1.8B

17.21%1.7B

15.88%1.64B

14.23%1.65B

13.20%1.57B

Other composite income

27.68%746.75M

-21.79%724.5M

-25.00%636.33M

-62.49%366.93M

-51.08%584.87M

0.47%926.33M

-15.06%848.41M

-44.17%978.22M

129.11%1.2B

122.95%921.98M

Shareholders equity without minority interests

11.39%4.21B

1.76%4.1B

0.84%3.85B

-9.80%3.51B

-8.20%3.78B

7.16%4.03B

3.38%3.82B

-11.86%3.89B

28.18%4.12B

23.54%3.76B

Minority interests

-44.79%816.61K

-40.89%968.73K

279.18%1.21M

248.36%1.4M

288.96%1.48M

326.98%1.64M

155.84%318.65K

179.56%402.82K

-57.82%-782.78K

-31,053.27%-722.05K

Total shareholder equity

11.37%4.21B

1.74%4.1B

0.86%3.85B

-9.77%3.51B

-8.15%3.78B

7.23%4.03B

3.41%3.82B

-11.84%3.89B

28.17%4.11B

23.52%3.76B

Total liabilityies and equity

9.18%4.68B

-1.34%4.52B

-1.70%4.33B

-12.34%3.97B

-9.89%4.29B

7.52%4.58B

5.91%4.4B

-8.64%4.53B

31.34%4.76B

26.92%4.26B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Lixin Certified Public Accountants (Special General Partnership)

	(Q3)Mar 31, 2025	(FY)Dec 31, 2024	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022
Assets
Current assets
Money funds	-14.19%686.18M	-1.43%593.31M	110.53%1.2B	14.21%665.56M	11.83%799.69M	-13.35%601.94M	-60.42%571.46M	-56.46%582.75M	-46.91%715.12M	-48.35%694.69M
Transactional financial assets	62.40%192.92M	20.00%180.02M	-24.97%120.44M	253.30%116.18M	27.20%118.8M	10.24%150.01M	1.18%160.52M	-69.71%32.89M	-19.46%93.39M	165.45%136.07M
Notes receivable and accounts receivable	-8.09%520.41M	-10.83%471.99M	-13.66%439.89M	-16.98%526.06M	-12.39%566.23M	-0.19%529.32M	-3.48%509.51M	22.89%633.63M	3.00%646.29M	-6.63%530.33M
-Notes receivable	-8.50%199.24M	-2.18%155.49M	-31.18%153.31M	-27.76%208.57M	-14.50%217.75M	2.13%158.96M	4.85%222.77M	41.15%288.71M	4.03%254.7M	-29.76%155.65M
-Accounts receivable	-7.84%321.17M	-14.54%316.5M	-0.05%286.58M	-7.96%317.48M	-11.01%348.48M	-1.15%370.36M	-9.10%286.73M	10.88%344.93M	2.34%391.59M	8.17%374.68M
Other receivables (including interest and dividends)	-98.16%230.63K	-69.95%124.54K	-99.08%526.39K	-98.82%346K	-49.52%12.54M	-98.84%414.42K	-1.79%56.99M	-55.02%29.31M	-56.64%24.85M	-23.53%35.77M
-Accrued interest receivable	----	----	----	----	----	----	-29.26%36.73M	-54.53%26.72M	-58.86%21.49M	-23.82%34.84M
-Other receivable	----	----	----	-86.65%346K	----	-55.28%414.42K	----	-59.54%2.59M	----	-10.78%926.6K
Advance payment	323.68%25.11M	-3.75%6.55M	-38.24%16.45M	106.06%68.97M	-63.79%5.93M	-47.34%6.81M	250.10%26.64M	36.61%33.47M	263.66%16.37M	29.84%12.93M
Inventories	16.85%186.01M	9.35%187.85M	13.51%188.41M	-0.43%151.72M	1.63%159.19M	6.84%171.79M	2.93%165.98M	-3.19%152.37M	-4.86%156.64M	-2.63%160.8M
Non-current assets due within one year	--1.09B	--924.87M	----	----	----	----	----	----	----	----
Other current assets	-43.25%10.15M	247.08%50.64M	215.32%45.71M	299.24%26.03M	223.00%17.88M	279.90%14.59M	15,194.64%14.5M	-49.01%6.52M	-53.33%5.54M	-61.71%3.84M
Total current assets	61.35%2.71B	63.77%2.42B	33.80%2.01B	5.71%1.55B	1.33%1.68B	-6.32%1.47B	-36.13%1.51B	-35.51%1.47B	-30.53%1.66B	-30.16%1.57B
Non Current assets
Other equity investment	22.03%1.05B	-18.90%1.02B	-21.37%920.64M	-54.39%603.69M	-45.54%860.09M	0.36%1.26B	-13.77%1.17B	-41.01%1.32B	98.27%1.58B	87.92%1.26B
Other non-current financial assets	7.62%51.53M	7.62%51.53M	3.93%47.89M	3.93%47.89M	3.93%47.89M	3.93%47.89M	9.77%46.07M	9.77%46.07M	9.77%46.07M	9.77%46.07M
Long-term equity investment	----	----	----	----	----	----	-58.26%7.25M	-58.26%7.25M	-51.56%8.41M	--8.41M
Fixed assets	----	----	----	-3.28%276.44M	----	-2.99%289.57M	----	10.79%285.81M	----	9.08%298.49M
Constru in process	----	----	----	-94.40%884.02K	----	-91.58%520K	----	-65.44%15.77M	----	-81.91%6.18M
Intangible assets	277.31%167.5M	274.20%168.8M	285.85%170.15M	281.57%171.45M	2.15%44.39M	1.99%45.11M	7.15%44.1M	7.65%44.93M	2.69%43.46M	3.09%44.23M
Goodwill	----	----	----	----	----	----	-34.46%9.04M	-34.46%9.04M	-34.46%9.04M	-34.46%9.04M
Long deferred expense	994.94%2.32M	1,051.84%2.44M	384.78%1.83M	419.53%1.67M	-28.12%212.16K	-34.29%212.16K	--376.99K	--321.64K	--295.18K	--322.86K
Deferred tax assets	-25.34%24.39M	-6.87%29.44M	74.46%27.87M	39.14%25.19M	77.74%32.67M	73.08%31.61M	-5.14%15.98M	17.12%18.1M	18.71%18.38M	20.93%18.26M
Other non current assets	-69.44%408.91M	-60.81%559.67M	-33.16%874.64M	-1.48%1.29B	22.43%1.34B	43.31%1.43B	--1.31B	--1.31B	12,829.63%1.09B	9,165.66%996.49M
Total non current assets	-24.44%1.97B	-32.26%2.1B	-20.15%2.31B	-21.02%2.42B	-15.90%2.61B	15.64%3.1B	60.98%2.9B	14.24%3.06B	150.91%3.1B	143.77%2.68B
Total assets	9.18%4.68B	-1.34%4.52B	-1.70%4.33B	-12.34%3.97B	-9.89%4.29B	7.52%4.58B	5.91%4.4B	-8.64%4.53B	31.34%4.76B	26.92%4.26B
Liabilities
Current liabilities
Short term loan	--6.17M	--5.42M	--2.99M	----	----	----	----	----	----	----
Notes payable and accounts payable	2.53%202.22M	-26.31%99.37M	91.47%218.99M	26.36%229.97M	23.45%197.23M	48.17%134.85M	39.64%114.38M	198.12%182M	34.29%159.77M	21.32%91.01M
-Accounts payable	2.53%202.22M	-26.31%99.37M	91.47%218.99M	26.36%229.97M	23.45%197.23M	48.17%134.85M	39.64%114.38M	198.12%182M	34.29%159.77M	21.32%91.01M
Contract liabilities	-48.70%14.46M	-60.34%18.12M	2.20%18.97M	-39.91%15.58M	13.03%28.18M	14.10%45.69M	18.74%18.56M	7,829.67%25.93M	1,070.30%24.93M	1,289.74%40.04M
Advance receipts	--165K	--165K	----	----	----	----	----	----	----	----
Salaries payable	-47.10%550.73K	-44.92%1.08M	72.36%7.11M	68.12%7.37M	8.37%1.04M	148.97%1.96M	72.07%4.12M	123.54%4.38M	-22.66%960.67K	-59.15%788.02K
Taxs payable	-38.05%25.1M	-6.60%57.29M	-44.96%18.98M	-6.97%19.87M	32.35%40.52M	-3.54%61.34M	11.45%34.48M	7.45%21.35M	-2.36%30.61M	288.70%63.59M
Other payable (including interest and dividends)	-73.63%23.03M	-42.11%47.83M	-77.56%45.43M	-59.86%71.3M	-48.65%87.33M	-6.42%82.62M	95.12%202.49M	65.12%177.64M	52.59%170.06M	2.16%88.29M
-Other payable	----	----	----	-59.86%71.3M	----	-6.42%82.62M	----	65.12%177.64M	----	2.16%88.29M
Other current liabilities	321.63%13.06M	-63.97%3.02M	-63.95%4.19M	-65.76%5.96M	-57.60%3.1M	-31.45%8.39M	85.97%11.64M	--17.4M	-18.25%7.31M	51.63%12.24M
Total current liabilities	-20.33%284.74M	-30.62%232.3M	-17.89%316.66M	-18.35%350.05M	-9.21%357.39M	13.14%334.85M	60.09%385.66M	124.70%428.7M	43.62%393.63M	55.21%295.96M
Current liabilities
Deferred tax liabilities	28.21%139.04M	-19.91%135.11M	-21.49%117.53M	-59.46%69.99M	-48.62%108.45M	3.65%168.71M	-15.11%149.7M	-44.17%172.65M	128.98%211.07M	122.79%162.77M
Long term deferred income	14.57%47.5M	11.03%48.03M	-14.58%38.7M	6.36%40.11M	8.87%41.46M	9.49%43.26M	3.66%45.31M	-16.48%37.71M	-16.64%38.08M	-16.23%39.51M
Total non current liabilities	24.44%186.54M	-13.60%183.15M	-19.89%156.23M	-47.66%110.1M	-39.83%149.9M	4.79%211.97M	-11.38%195.01M	-40.64%210.37M	80.73%249.15M	68.25%202.28M
Total liabilities	-7.10%471.28M	-24.02%415.45M	-18.56%472.89M	-28.00%460.15M	-21.08%507.29M	9.75%546.82M	25.97%580.67M	17.22%639.07M	56.04%642.78M	60.25%498.24M
Shareholders equity
Paid-in capital	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B	0.00%1.05B
Capital reserve funds	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M	0.00%8.62M
Surplus reserve funds	14.36%288.62M	14.36%288.62M	16.09%252.36M	16.09%252.37M	16.09%252.37M	16.09%252.37M	13.35%217.39M	13.35%217.39M	13.35%217.39M	13.35%217.39M
Retained profit	12.31%2.12B	13.15%2.03B	12.30%1.91B	11.90%1.84B	14.47%1.89B	14.68%1.8B	17.21%1.7B	15.88%1.64B	14.23%1.65B	13.20%1.57B
Other composite income	27.68%746.75M	-21.79%724.5M	-25.00%636.33M	-62.49%366.93M	-51.08%584.87M	0.47%926.33M	-15.06%848.41M	-44.17%978.22M	129.11%1.2B	122.95%921.98M
Shareholders equity without minority interests	11.39%4.21B	1.76%4.1B	0.84%3.85B	-9.80%3.51B	-8.20%3.78B	7.16%4.03B	3.38%3.82B	-11.86%3.89B	28.18%4.12B	23.54%3.76B
Minority interests	-44.79%816.61K	-40.89%968.73K	279.18%1.21M	248.36%1.4M	288.96%1.48M	326.98%1.64M	155.84%318.65K	179.56%402.82K	-57.82%-782.78K	-31,053.27%-722.05K
Total shareholder equity	11.37%4.21B	1.74%4.1B	0.86%3.85B	-9.77%3.51B	-8.15%3.78B	7.23%4.03B	3.41%3.82B	-11.84%3.89B	28.17%4.11B	23.52%3.76B
Total liabilityies and equity	9.18%4.68B	-1.34%4.52B	-1.70%4.33B	-12.34%3.97B	-9.89%4.29B	7.52%4.58B	5.91%4.4B	-8.64%4.53B	31.34%4.76B	26.92%4.26B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion
Auditor	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)	--	--	--	Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

300039 Shanghai Kaibao Pharmaceutical

Shanghai Kaibao Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Market Insights

Discussing

Latest News

Investment Course